Enantioselective metabolism of the designer drugs 3,4-methylenedioxymethamphetamine (‘ecstasy’) and 3,4-methylenedioxyethylamphetamine (‘eve’) isomers in rat brain and blood

This publication has 13 references indexed in Scilit:

• Stereospecific analysis of ecstasy-like N-ethyl-3,4-methylenedioxyamphetamine and its metabolites in humans
  Journal of Chromatography B: Biomedical Sciences and Applications, 2001
• Ecstasy (MDMA): a review of its possible persistent psychological effects
  Psychopharmacology, 2000
• Identification of the human cytochromes P450 involved in the oxidative metabolism of “Ecstasy”-related designer drugs
  Biochemical Pharmacology, 2000
• (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals
  Neuropsychobiology, 2000
• Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)
  Toxicology Letters, 2000
• Stereoselective disposition: Enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry
  Journal of Mass Spectrometry, 1993
• Psychological Effects of MDE in Normal Subjects
  Neuropsychopharmacology, 1993
• 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain
  European Journal of Pharmacology, 1987
• Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens
  Journal of Psychoactive Drugs, 1986
• Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)
  Journal of Pharmaceutical Sciences, 1980